Medindia

X

R82 Launches Flamingo High-Low Toilet and Bathing Chair

Thursday, July 7, 2016 Research News J E 4
Advertisement
High-Low Chair can be Used in Multiple Configurations

MATTHEWS, N.C., July 6, 2016 /PRNewswire-iReach/ -- Etac NA Marketing Director, Nanneke Dinklo, today announced the launch of the R82 Flamingo, a multi-purpose toilet and bathing chair that can be used in freestanding position, fixed over the toilet or in the bathtub.  The Flamingo High-Low was designed for children with mild to severe involvement, with tilt-in-space and back recline functions and offers a smooth and stepless height adjustment.

Photo - http://photos.prnewswire.com/prnh/20160705/386271

The Flamingo High-Low comes in four seat sizes with widths varying from 10" to 18-1/2".  The Flamingo can be used with either the standard Flamingo base or the High-Low base, comes in two sizes and is height adjustable.

The Flamingo High-Low comes with a gas-assisted foot pedal for easy height adjustment that allows for a range from 20.75 to 29-inches that can be operated while the user is seated, for optimal ergonomic working position.  The Flamingo tilts from -5 degrees to 40 degrees and back reclines up to 45-degrees, ensuring a child's optimum comfort and positioning.

"Simplified daily living functions make personal hygiene more effective and easier for the caretaker and much less cumbersome for the child. The R82 line of bathing and toileting products are effective and easy to use, making bath time more enjoyable for special needs children while affording parents and other caregivers a good ergonomic working position," Dinklo said.

The R82 Flamingo High-low highlights:

  • Comes with two bases and four seat sizes
  • Offers multi-purpose functions  
  • Allows for fluid height adjustment from 20.75" to 29" through a gas-assisted foot pedal
  • Tilts and reclines for optimal positioning

The Etac NA brands offer pediatric products typically prescribed to individuals with mild to moderate involvement of the following conditions:  Cerebral Palsy, Down Syndrome, Duchene Muscular Dystrophy, Spinal Muscular Atrophy, Spina Bifida, Osteogenesis Imperfecta, Traumatic Brain Injury, Spinal Cord Injury, Cystic Fibrosis, Mitochondrial Disease, Metabolic Diseases, and Sensory Processing Disorders, among others.

About Etac North America

The Etac Group offers a wide range of solutions for children and adults ranging from manual wheelchairs, advanced seating, patient transfer, bathing and toilet products. Sweden-based Etac markets their products under the Etac, Molift, Immedia, R82 and Convaid brands. Etac operates sales companies in Sweden, Norway, Denmark, Germany, the Netherlands, the United Kingdom, Australia and the United States with an extensive network of distributors in 40 other markets around the world.

Based in Denmark, R82 develops and produces innovative aids and appliances for special need children and young adults. These are tailored to individual needs based on comprehensive product development and clinical input. R82 prides itself on a high caliber of quality of service and customer engagement.

Convaid, the company that invented the adaptive assisted wheelchair, has helped special needs children and their families live fuller, more productive lives since 1976. Convaid produces high-performance, easy-to-use and attractive mobility products for all stages of a young person's life, from infancy to young adulthood. Each product is custom-built to individual specifications to provide optimum comfort, safety and convenience. 

Together R82 and Convaid form the Etac Pediatric Group.

Links:

R82 website  

Etac website  

Convaid Community Blog     

R82 Facebook

Convaid Facebook  

Convaid website   

Media Contact: Milena Rimassa, Convaid Products, Inc., 310-618-0111, milena@convaid.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Convaid Products, Inc.

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Catasys Expands Rollout of OnTrak-H Solution in Vi...
S
FDA Grants Merrimack Fast Track Designation for Se...